Confused About AML Genetic Testing and Treatment What You Need to Know.

Confused About AML Genetic Testing and Treatment? What You Need to Know.

/in , , , , , , /by

 

What is AML genetic testing? Dr. Alice Mims explains genetic testing in AML, including the necessity of testing, the effect on treatment decisions, and why patients should be retested over the course of their disease.

About the Guest:
Dr. Alice Mims is a hematologist specializing in acute and chronic myeloid conditions. She serves as the Acute Leukemia Clinical Research Director at The Ohio State University Comprehensive Cancer Center – James.

You might also like
Advancements in AML Treatment | Tailoring Therapies to Individual PatientsAdvancements in AML Treatment | Tailoring Therapies to Individual Patients
Misconceptions in Clinical Trials: What’s Fact and What’s FictionMisconceptions in Clinical Trials: What’s Fact and What’s Fiction?
Assessing Untreated AML Patients Who Are Ineligible for Intensive ChemotherapyAssessing Untreated AML Patients Who Are Ineligible for Intensive Chemotherapy
How Have Advances in Testing Impacted AML CareHow Have Advances in Testing Impacted AML Care?
AML Targeted Therapies, What’s Available and How Do They WorkAML Targeted Therapies, What’s Available and How Do They Work?
Facing Acute Myeloid Leukemia: Notes from a SurvivorFacing Acute Myeloid Leukemia: Notes from a Survivor